SI1725526T1 - Postopek priprave pirolidoin-oksimov - Google Patents

Postopek priprave pirolidoin-oksimov

Info

Publication number
SI1725526T1
SI1725526T1 SI200530122T SI200530122T SI1725526T1 SI 1725526 T1 SI1725526 T1 SI 1725526T1 SI 200530122 T SI200530122 T SI 200530122T SI 200530122 T SI200530122 T SI 200530122T SI 1725526 T1 SI1725526 T1 SI 1725526T1
Authority
SI
Slovenia
Prior art keywords
preparing pyrrolidine
oximes
pyrrolidine oximes
preparing
formula
Prior art date
Application number
SI200530122T
Other languages
English (en)
Inventor
William Nadler
Doris Pupowicz
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Publication of SI1725526T1 publication Critical patent/SI1725526T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI200530122T 2004-02-26 2005-02-28 Postopek priprave pirolidoin-oksimov SI1725526T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04100773 2004-02-26
PCT/EP2005/050852 WO2005082848A2 (en) 2004-02-26 2005-02-28 Method for preparing pyrrolidine oximes
EP05708062A EP1725526B1 (en) 2004-02-26 2005-02-28 Method for preparing pyrrolidine oximes

Publications (1)

Publication Number Publication Date
SI1725526T1 true SI1725526T1 (sl) 2008-04-30

Family

ID=34896105

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530122T SI1725526T1 (sl) 2004-02-26 2005-02-28 Postopek priprave pirolidoin-oksimov

Country Status (21)

Country Link
US (1) US20070197794A1 (sl)
EP (1) EP1725526B1 (sl)
JP (1) JP2007524702A (sl)
KR (1) KR20060124775A (sl)
CN (1) CN1946686A (sl)
AT (1) ATE380792T1 (sl)
AU (1) AU2005217153A1 (sl)
BR (1) BRPI0508059A (sl)
CA (1) CA2554767A1 (sl)
CY (1) CY1107139T1 (sl)
DE (1) DE602005003803T2 (sl)
DK (1) DK1725526T3 (sl)
EA (1) EA011026B1 (sl)
ES (1) ES2296137T3 (sl)
IL (1) IL177388A0 (sl)
NO (1) NO20064352L (sl)
PL (1) PL1725526T3 (sl)
PT (1) PT1725526E (sl)
SI (1) SI1725526T1 (sl)
UA (1) UA86226C2 (sl)
WO (1) WO2005082848A2 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2845850A1 (en) * 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
EP3164384B1 (en) 2014-07-02 2019-12-04 ObsEva S.A. Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one o-methyloxime useful in methods of treating conditions related to the ot-r activity
WO2021165927A1 (en) * 2020-02-21 2021-08-26 Wockhardt Bio Ag 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329418B1 (en) * 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
US7211601B2 (en) * 2000-03-27 2007-05-01 Applied Research Systems Ars Holding N.V. Pharmaceutically active pyrrolidine derivatives
RS99503A (en) * 2001-06-18 2006-12-15 Applied Research Systems Ars Holding N.V. Pyrrolidine oxadiazole- and thiadiazole derivatives

Also Published As

Publication number Publication date
DE602005003803T2 (de) 2008-12-24
US20070197794A1 (en) 2007-08-23
UA86226C2 (en) 2009-04-10
ES2296137T3 (es) 2008-04-16
AU2005217153A1 (en) 2005-09-09
CN1946686A (zh) 2007-04-11
WO2005082848A2 (en) 2005-09-09
JP2007524702A (ja) 2007-08-30
DK1725526T3 (da) 2008-03-03
KR20060124775A (ko) 2006-12-05
CA2554767A1 (en) 2005-09-09
WO2005082848A3 (en) 2005-12-01
EA200601456A1 (ru) 2007-02-27
EP1725526A2 (en) 2006-11-29
EA011026B1 (ru) 2008-12-30
CY1107139T1 (el) 2012-10-24
EP1725526B1 (en) 2007-12-12
ATE380792T1 (de) 2007-12-15
IL177388A0 (en) 2006-12-10
BRPI0508059A (pt) 2007-07-17
DE602005003803D1 (de) 2008-01-24
PL1725526T3 (pl) 2008-03-31
NO20064352L (no) 2006-09-26
PT1725526E (pt) 2007-12-27

Similar Documents

Publication Publication Date Title
UA96971C2 (ru) Способ получения фторметилзамещенных гетероциклических соединений
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
DE602005019078D1 (de) Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit
MX2007006397A (es) Derivados de tetrahidropirano.
TW200740752A (en) 4-Biarylyl-1-phenylazetidin-2-ones
MX2007007845A (es) Sulfonilpirrolidinas, metodo para producir las mismas y su uso como medicamento.
TW200726767A (en) Chemical compounds 2
TW200616995A (en) Novel compounds
GB0305142D0 (en) Synthesis
WO2006020664A3 (en) Ammonolysis process for the preparation of intermediates for dpp iv inhibitors
MXPA05012362A (es) Yodopirazolilcarboxanilidas.
SI1751093T1 (sl) Substituirani derivati cikloheksilocetne kisline
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
WO2004071390A3 (en) Piperazine-2-carboxamide derivatives
NO20055750L (no) Nye kjemiske forbindelser
PL1745010T3 (pl) Podstawione pochodne cykloheksylo-1,4-diaminy
TW200745106A (en) Chemical compounds
IL177388A0 (en) Method for preparing pyrrolidine oximes
MX2009000767A (es) Sintesis de (2s,5r)-5-etinil-1-{n-(4-metil-1-(4-carboxi-piridin-2- il)piperidin-4-il)glicil}pirrolidina-2-carbonitrilo.
WO2008102888A1 (ja) 新規擬似糖脂質及びその用途
IL183104A0 (en) Method for production of candesartan
MX2008000821A (es) Nuevos derivados de piperidina.